(Q38435775)

3 September 2017

COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma (English)

1 reference

3 September 2017

1 reference

Serkan Erkanli

1

1 reference

3 September 2017

Filiz Bolat

2

1 reference

3 September 2017

Fazilet Kayaselcuk

3

1 reference

3 September 2017

Beyhan Demirhan

4

1 reference

3 September 2017

Esra Kuscu

5

1 reference

3 September 2017

language of work or name

English

0 references

publication date

9 October 2006

1 reference

3 September 2017

1 reference

3 September 2017

104

1 reference

3 September 2017

320-325

1 reference

3 September 2017

2

1 reference

3 September 2017

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

7 January 2021

Towards a better aspirin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

The Role of Cytokines in the Production of Prostacyclin and Thromboxane in Human Mononuclear Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Survivin and apoptosis control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

COX-2-dependent stabilization of survivin in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Role of cyclooxygenase-2 in immunomodulation and prognosis of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Expression of cyclo-oxygenase-2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squamous cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Correlation of survivin mRNA detection with histologic diagnosis in normal endometrium and endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Survivin expression in endometrial carcinoma: a tissue microarray study with correlation with PTEN and STAT-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

The relationship between oncogene expression and clinical outcome in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

Expression of cyclooxygenase 2 by prostaglandin E(2) in human endometrial adenocarcinoma cell line HEC-1B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.044

10.1016/J.YGYNO.2006.08.044

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference